15:30 – quinta-feira, 15 de outubro de 2015

For both scientists and clinicians, the appeal of immuno-oncology is in the possibility of harnessing a patient’s immune system to achieve tumor control, stabilization, and potential eradication of disease.

Elucidation of these immune responses, as well as investigating existing therapies for their ability to induce antitumor immune responses, is critical to give rise to more promising combination immunotherapies, in addition to development of novel therapeutics.

In this webinar, leaders in immuno-oncology, Jedd Wolchok, Padmanee Sharma, K. Dane Wittrup, and Peter Johnson will discuss the importance of and recent advances in immuno-oncology strategies with combination therapies.

Acesse aqui para se inscrever.